Mark Tristan J. Quimque

Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms

Mark Tristan J. Quimque, Kin Israel Notarte, Rey Arturo T. Fernandez et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 132 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched <i>n</i>-Butanol Fraction from <i>Uvaria alba</i>

Kin Israel Notarte, Mark Tristan J. Quimque, Imee Macaranas et al. · ACS Omega · 2023 · 79 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from <i>Uvaria alba</i>: Insights from <i>In Vitro</i> and Consensus Virtual Screening

Mark Tristan J. Quimque, Kin Israel Notarte, arianne letada et al. · ACS Omega · 2021 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis

Von Novi O. de Leon, Joe Anthony Manzano, Delfin Yñigo H. Pilapil et al. · Journal of Genetic Engineering and Biotechnology · 2021 · 41 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Enhanced Oral Bioavailability of the Pharmacologically Active Lignin Magnolol via Zr-Based Metal Organic Framework Impregnation

Joshua Santos, Mark Tristan J. Quimque, Allan Patrick G. Macabeo et al. · Pharmaceutics · 2020 · 35 citations · Full text

Pharmacy, Pharmacology, Toxicology +11